Obesity and novel cardiovascular markers in a population without diabetes and cardiovascular disease in China. (Q51589831)

7 April 2018

title

Obesity and novel cardiovascular markers in a population without diabetes and cardiovascular disease in China. (English)

1 reference

7 April 2018

main subject

obesity

0 references

cardiovascular disease

1 reference

Qiang Zeng

1

1 reference

7 April 2018

Sheng-Yong Dong

2

1 reference

7 April 2018

Man-Liu Wang

3

1 reference

7 April 2018

Jin-Ming Li

4

1 reference

7 April 2018

Chong-Lei Ren

5

1 reference

7 April 2018

Chang-Qing Gao

6

1 reference

7 April 2018

language of work or name

English

0 references

publication date

3 August 2016

1 reference

7 April 2018

published in

Preventive Medicine

1 reference

7 April 2018

volume

91

1 reference

7 April 2018

page(s)

62-69

1 reference

7 April 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Obesity and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Understanding amino-terminal pro-B-type natriuretic peptide in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

An index approach for the Cox model with left censored covariates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

The metabolic syndrome is an important concept in therapeutic decision-making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Does body mass index adequately convey a patient's mortality risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Aortic stiffness, blood pressure progression, and incident hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Secular trends in prevalence of overweight and obesity among adults in rural Tianjin, China from 1991 to 2011: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Body-mass index and mortality among adults with incident type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Adipose tissue biology and cardiomyopathy: translational implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Percent body fat is a better predictor of cardiovascular risk factors than body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

Ideal cardiovascular health in Chinese urban population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.08.001

10.1016/J.YPMED.2016.08.001

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

27497658

1 reference

7 April 2018